Company Filing History:
Years Active: 2013
Title: Ho-Sung Min: Innovator in Biologically Active Peptides
Introduction
Ho-Sung Min is a notable inventor based in Sungnam-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of peptides that can modulate nerve growth factor (NGF) activity. His work has the potential to impact therapeutics for various diseases linked to NGF.
Latest Patents
Ho-Sung Min holds 1 patent related to his innovative research. The patent focuses on "Peptides and related molecules that modulate nerve growth factor activity." This invention pertains to biologically active peptides and polypeptides that can be utilized as therapeutics or prophylactics against diseases associated with NGF. One aspect of this invention includes pharmacologically active polypeptides that comprise peptides linked to one or more Fc domains.
Career Highlights
Ho-Sung Min is currently employed at Amgen Inc., a leading biotechnology company known for its innovative therapies. His work at Amgen has allowed him to further explore the therapeutic applications of his inventions in the field of nerve growth and regeneration.
Collaborations
Some of his notable coworkers include Thomas Charles Boone and Kenneth D Wild, Jr. Their collaboration has likely contributed to the advancement of research in the field of biologically active peptides.
Conclusion
Ho-Sung Min's contributions to the field of biotechnology, particularly through his patent on peptides that modulate NGF activity, highlight his role as an innovator. His work at Amgen Inc. continues to pave the way for potential therapeutic advancements.